Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: Head and Neck Neoplasms trials
The registry lists 12 Head and Neck Neoplasms studies with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor. 3 are open to participants now and 3 have results posted.
Phase 1 4Phase 2 4No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)RecruitingNCT07209189Phase 2
- Immunobiology Blood and Tissue Collection of Upper Aerodigestive MalignanciesRecruitingNCT05995821
- Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric PatientsRecruitingNCT05658731Not applicable
- Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHNCompletedNCT03878979Phase 2Results posted
- RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHNTerminatedNCT01009346Phase 1/2Results posted
- A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCCTerminatedNCT00882583Phase 1Results posted
- Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer PatientsWithdrawnNCT03372148Not applicable
- Head and Neck Cancer Treatment Related DysphagiaWithdrawnNCT02657850
- A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive CancersCompletedNCT02188563Not applicable
- Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer PatientsTerminatedNCT01493154Phase 1
- MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00427102Phase 1
- Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck CancerCompletedNCT00281866Phase 2